Regulation of IgE synthesis by CD23/CD21 interaction.
At least two cell-derived signals have been shown to be necessary for the induction of immunoglobulin isotype switching in B cells. The first signal is given by either of the soluble lymphokines interleukin (IL)-4 or IL-13 which induce germline epsilon transcript expression, but alone is insufficient to trigger secretion of IgE. The second signal is provided by a physical interaction between B cells and activated T cells, basophils and mast cells, and it has been shown that the CD40/CD40L pairing is crucial for mediating IgE synthesis. In HIGM1 syndrome, which is characterized by greatly decreased levels of IgG, IgA and IgE, there are mutations in CD40L resulting in a completely non-functional extracellular domain. CD40L is therefore playing a central role in Ig switching. Amongst the numerous pairs of surface adhesion molecules, the CD23/CD21 pair seems to play a key role in the generation of IgE. The CD23 molecule is positively and negatively regulated by factors which increase or decrease IgE production, respectively. Antibodies to CD23 have been shown to inhibit IL-4-induced human IgE production in vitro and to inhibit antigen-specific IgE responses in a rat model, in an isotype-selective manner. CD23 interacts with CD21 on B cells, preferentially driving IgE production. CD23 recognises two main epitopes on the CD21 molecule. One region consists of short consensus repeat sequences (SCRs) 1-2 and the other of SCRs 5-8. In the latter region ASn370 and Asn295 are critical in the interaction with the lectin CD23. Therefore, a restricted number of cytokines and surface molecules seems to selectively regulate human IgE synthesis.
Bonnefoy
J Y
JY
Glaxo Institute for Molecular Biology, Geneva, Switzerland.
Gauchat
J F
JF
Life
P
P
Graber
P
P
Aubry
J P
JP
Lecoanet-Henchoz
S
S
D000818:Animals; D015703:Antigens, CD / Q000502:physiology; D000944:Antigens, Differentiation, B-Lymphocyte / Q000502:physiology; D001402:B-Lymphocytes / Q000276:immunology; D019013:CD40 Antigens; D023201:CD40 Ligand; D002448:Cell Adhesion; D016384:Consensus Sequence; D004854:Herpesvirus 4, Human / Q000502:physiology; D006801:Humans; D017578:Immunoglobulin Class Switching / Q000502:physiology*; D007073:Immunoglobulin E / Q000096:biosynthesis*; D018793:Interleukin-13 / Q000494:pharmacology; D015847:Interleukin-4 / Q000494:pharmacology; D008211:Lymphocyte Cooperation; D008562:Membrane Glycoproteins / Q000502:physiology; D016297:Mutagenesis, Site-Directed; D017464:Receptors, Complement 3d / Q000235:genetics / Q000502:physiology*; D017455:Receptors, IgE / Q000502:physiology*; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology; D014764:Viral Proteins / Q000494:pharmacology
D015703:Antigens, CD; D000944:Antigens, Differentiation, B-Lymphocyte; D019013:CD40 Antigens; D018793:Interleukin-13; D008562:Membrane Glycoproteins; D017464:Receptors, Complement 3d; D017455:Receptors, IgE; D014764:Viral Proteins; D023201:CD40 Ligand; D015847:Interleukin-4; D007073:Immunoglobulin E